Question of the Week - January 16th
Semaglutide (Ozempic) is a newly approved GLP-1 Receptor Agonist with a few unique features. Which of the following statements is true about Semaglutide (Ozempic)?
0 points
Submit
This form was created inside of Diabetes Educational Services. Report Abuse - Terms of Service - Additional Terms